Disseminated primary varicella infection during infliximab treatment

Research output: Contribution to journalArticleAcademicpeer-review

50 Citations (Scopus)

Abstract

A young man developed a serious disseminated varicella infection, necessitating antiviral treatment, after being treated with anti-tumor necrosis factor-alpha therapy for rheumatoid arthritis.
Original languageUndefined
Pages (from-to)2517-2518
JournalJournal of rheumatology
Volume31
Issue number12
Publication statusPublished - 2004

Keywords

  • METIS-223732
  • IR-101215

Cite this

@article{bc8e67c5f6f74e769b3dfc0e2f6d693d,
title = "Disseminated primary varicella infection during infliximab treatment",
abstract = "A young man developed a serious disseminated varicella infection, necessitating antiviral treatment, after being treated with anti-tumor necrosis factor-alpha therapy for rheumatoid arthritis.",
keywords = "METIS-223732, IR-101215",
author = "Vonkeman, {Harald Erwin} and {ten Napel}, Chris and Rasker, {Johannes J.} and {van de Laar}, {Mart A F J}",
year = "2004",
language = "Undefined",
volume = "31",
pages = "2517--2518",
journal = "Journal of rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "12",

}

Disseminated primary varicella infection during infliximab treatment. / Vonkeman, Harald Erwin; ten Napel, Chris; Rasker, Johannes J.; van de Laar, Mart A F J.

In: Journal of rheumatology, Vol. 31, No. 12, 2004, p. 2517-2518.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Disseminated primary varicella infection during infliximab treatment

AU - Vonkeman, Harald Erwin

AU - ten Napel, Chris

AU - Rasker, Johannes J.

AU - van de Laar, Mart A F J

PY - 2004

Y1 - 2004

N2 - A young man developed a serious disseminated varicella infection, necessitating antiviral treatment, after being treated with anti-tumor necrosis factor-alpha therapy for rheumatoid arthritis.

AB - A young man developed a serious disseminated varicella infection, necessitating antiviral treatment, after being treated with anti-tumor necrosis factor-alpha therapy for rheumatoid arthritis.

KW - METIS-223732

KW - IR-101215

M3 - Article

VL - 31

SP - 2517

EP - 2518

JO - Journal of rheumatology

JF - Journal of rheumatology

SN - 0315-162X

IS - 12

ER -